STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumorsHeehyoung Lee, Hua Yu, George Somlo et al.|Nature Medicine|2010Cited by 395
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responsesMarcin Kortylewski, Hua Yu, Piotr Swiderski et al.|Nature Biotechnology|2009Cited by 378
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)David R. Wise, Kwok‐Kin Wong, Russell K. Pachynski et al.|Prostate Cancer and Prostatic Diseases|2024Cited by 9
<i>In vivo</i> metabolomics identifies CD38 as an emergent vulnerability in <i>LKB1</i> -mutant lung cancerJiehui Deng, Kwok‐Kin Wong|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 1